| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/29/2003 | US6555525 Microencapsulation and sustained release of oligonucleotides |
| 04/29/2003 | US6555156 Process for making absorbable microparticles |
| 04/29/2003 | US6555146 Sugar-free foodstuff products |
| 04/29/2003 | US6555139 Preparation of micron-size pharmaceutical particles by microfluidization |
| 04/29/2003 | US6555138 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances |
| 04/29/2003 | US6555137 Sucralfate-containing composition and process for the preparation thereof |
| 04/29/2003 | US6555136 Pharmaceutical dosage form for pulsatile delivery of methylphenidate |
| 04/29/2003 | US6555135 Comicronized with excipient having no therapeutic activity that is not a surfactant. |
| 04/29/2003 | US6555134 Synergistic mixtures of garlic and lycopene for preventing LDL oxidation |
| 04/29/2003 | US6555133 Oral dosage |
| 04/29/2003 | US6555132 Soft gelatin capsule manufacture |
| 04/29/2003 | US6555131 Solid solution of a copolymer of ethyl acrylate and methyl methacrylate containing about 5% trimethylammonium ethyl methacrylate chloride as the sole (meth)acrylate copolymer and an ester of a weak acid as plasticizer |
| 04/29/2003 | US6555130 Process for the continuous production and coating of self-adhesive compositions based on polyisobutylene with at least one active pharmaceutical substance |
| 04/29/2003 | US6555129 Transdermal therapeutic system (TTS) containing oxybutynin |
| 04/29/2003 | US6555127 Multi-spike release formulation for oral drug delivery |
| 04/29/2003 | US6555125 Microbiocides, antiinflammatories, antihistamines and mucoadhesives |
| 04/29/2003 | US6555124 Reversibly increasing the permeability to active agents of epithelial cells; applied orally, sublingually, buccally, rectally, pulmonarily or nasally or through the mucosa of the eye. |
| 04/29/2003 | US6555110 Microencapsulated compounds and method of preparing same |
| 04/29/2003 | US6555106 Providing particles of expanded matrix material to locus or vicinity of population of poultry during feed removal; particles contain bactericidal or bacteriostatic agents |
| 04/29/2003 | US6555098 Cosmetic deodorant products containing encapsulated bicarbonate and fragrance ingredients |
| 04/29/2003 | US6555093 Composition for the treatment of halitosis |
| 04/29/2003 | US6554822 Microbolus infusion pump |
| 04/29/2003 | US6554798 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
| 04/29/2003 | US6554791 Rapid infusion system |
| 04/29/2003 | US6554609 Nanotechnology for electrical devices |
| 04/29/2003 | CA2225797C Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals |
| 04/29/2003 | CA2219348C Solvent detergent emulsions having antiviral activity |
| 04/29/2003 | CA2159098C Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 04/29/2003 | CA2123160C Controlled release formulation |
| 04/25/2003 | CA2426925A1 Water-soluble liquid internal medicine |
| 04/25/2003 | CA2409910A1 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| 04/25/2003 | CA2409552A1 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| 04/24/2003 | WO2003034791A1 Mounting arrangement for auxiliary burner or lance |
| 04/24/2003 | WO2003033634A1 Low-viscosity opacifiers free from anionic surface-active agents |
| 04/24/2003 | WO2003033593A1 Ph responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery |
| 04/24/2003 | WO2003033592A1 Polymeric micelle composition with improved stability |
| 04/24/2003 | WO2003033527A2 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 04/24/2003 | WO2003033526A2 Synthesis of cyclosporin analogs |
| 04/24/2003 | WO2003033481A1 Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
| 04/24/2003 | WO2003033456A1 NOVEL β-PHENYL-α-OXYSUBSTITUTED PROPIONIC DERIVATIVES: PROCESS FOR ITS PREPARATION AND THEIR USE IN THE PREPARATION OF PHARMACEUTICALLY IMPORTANT COMPOUNDS |
| 04/24/2003 | WO2003033445A1 Stabilized compositions of aqueous reduced coenzyme q solution |
| 04/24/2003 | WO2003033097A2 Rotor-stator apparatus and process for the formation of particles |
| 04/24/2003 | WO2003033051A1 Laminated patient infusion device |
| 04/24/2003 | WO2003033031A1 Dosage form, device and methods of treatment |
| 04/24/2003 | WO2003033026A1 Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent |
| 04/24/2003 | WO2003033014A2 Novel use of pulmonary surfactant |
| 04/24/2003 | WO2003033012A1 Kahalalide compounds for use in cancer therapy |
| 04/24/2003 | WO2003033010A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 04/24/2003 | WO2003033000A1 Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma |
| 04/24/2003 | WO2003032998A1 Sustained-release fine particle and process for producing the same |
| 04/24/2003 | WO2003032983A1 Transdermal migraine therapy |
| 04/24/2003 | WO2003032978A1 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt |
| 04/24/2003 | WO2003032976A1 Method of treating dermatoses using avermectin compound |
| 04/24/2003 | WO2003032960A1 Percutaneous absorption preparations |
| 04/24/2003 | WO2003032959A1 Nanoparticulate compositions comprising inorganic cores |
| 04/24/2003 | WO2003032958A1 Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent |
| 04/24/2003 | WO2003032957A2 Methods for hermetically sealing microchip reservoir devices |
| 04/24/2003 | WO2003032956A1 Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl) quinazoline |
| 04/24/2003 | WO2003032955A1 Highly compressible ethylcellulose for tableting |
| 04/24/2003 | WO2003032954A1 Stabilized pharmaceutical formulations containing amlodipine maleate |
| 04/24/2003 | WO2003032953A1 Granules containing acid-unstable chemical in large amount |
| 04/24/2003 | WO2003032952A1 Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
| 04/24/2003 | WO2003032951A1 A process for preparing crystalline drug particles by means of precipitation |
| 04/24/2003 | WO2003032950A1 Pharmaceutical formulation comprising (r) -bicalutamide |
| 04/24/2003 | WO2003032949A1 Novel cyclosporin analog microemulsion preconcentrates |
| 04/24/2003 | WO2003032948A2 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity |
| 04/24/2003 | WO2003032947A2 A method for preparing liposome formulations with a predefined release profile |
| 04/24/2003 | WO2003032946A2 Ph-sensitive liposomes for targeted drug delivery |
| 04/24/2003 | WO2003032945A1 Binary composition for 'prime-boost' release of active ingredients like vaccines |
| 04/24/2003 | WO2003032944A1 Anti-microbial composition comprising a metal ion chelating agent |
| 04/24/2003 | WO2003032928A2 Therapeutic composition and use |
| 04/24/2003 | WO2003032924A2 Novel tibolone formulations |
| 04/24/2003 | WO2003032922A2 Stabilized azithromycin compositions |
| 04/24/2003 | WO2003032918A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 04/24/2003 | WO2003032907A2 High-concentration protein formulations and method of manufacture |
| 04/24/2003 | WO2003032906A2 Delivery of poorly soluble drugs |
| 04/24/2003 | WO2003032904A2 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 04/24/2003 | WO2003032896A2 Dexibuprofen-containing soft gelatin capsules and process for preparing the same |
| 04/24/2003 | WO2003032828A1 Methods and devices for preventing or healing injured nipples or areolas |
| 04/24/2003 | WO2003032815A2 Medical device for delivering patches |
| 04/24/2003 | WO2003032726A1 Antimicrobially-treated fabrics |
| 04/24/2003 | WO2003015701A9 Lipobeads and their production |
| 04/24/2003 | WO2003007915A3 Compositions for treatment of head and neck cancers, and methods of making and using the same |
| 04/24/2003 | WO2003007782A3 Biodegradable injectable implants and related methods of manufacture and use |
| 04/24/2003 | WO2002102376A8 ORALLY DELIVERABLE PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE COMPOUND HAVING AN AMINOSULFONYL GROUP (cox-2 INHIBITOR), A POLYETHYLENE GLYCOL AND A FREE-RADICAL SCAVENGING ANTIOXIDANT |
| 04/24/2003 | WO2002100437A3 Ophthalmic compositions comprising hyaluronic acid |
| 04/24/2003 | WO2002100389A8 Compressible guaifenesin compositions and method for producing them |
| 04/24/2003 | WO2002087614A3 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen |
| 04/24/2003 | WO2002085292A3 Improved method for treating aberrant fibrotic tisue manifestations with topical calcium channel blocker preparations and improved composition for such treatment and improved method for the manufacture thereof |
| 04/24/2003 | WO2002076509A3 Preparation for the prophylaxis of restenosis |
| 04/24/2003 | WO2002070438A3 Compositions for delivering bisphosphonates |
| 04/24/2003 | WO2002066490A3 Cationic sterol derivatives, ph-sensitive liposomes comprising cationic sterol derivatives and method for loading liposomes with active substances |
| 04/24/2003 | WO2002066025A3 Combination of active ingredients consisting of the racemate of tramadol and of (+)-o-desmethyltramadol |
| 04/24/2003 | WO2002066018A3 Transdermal therapeutic system containing testosterone and method for the production thereof |
| 04/24/2003 | WO2002062299A3 Improved controlled release oral dosage form |
| 04/24/2003 | WO2002056875A3 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance |
| 04/24/2003 | WO2002053137A3 Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 04/24/2003 | WO2002038171A3 METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE |
| 04/24/2003 | WO2002024180A3 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia |
| 04/24/2003 | WO2002012369A9 Lactic acid polymer and process for producing the same |